"Biokinetica to miejsce w którym tworzymy przyszłość medycyny."

During the past decade, Biokinetica SA conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Biokinetica SA" #1 sponsor was "Amgen" with 3 trials, followed by "Bayer" with 1 trials sponsored, "Celltrion" with 1 trials sponsored, "Cullinan Oncology, LLC" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Biokinetica SA" are "Advanced Solid Tumor" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Diabetic Retinopathy" (1 trials), "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Adenocarcinoma" (1 trials). Many other conditions were trialed in "Biokinetica SA" in a lesser frequency.

Most popular intervention types in "Biokinetica SA" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pembrolizumab" (2 trials), "AMG 757" (1 trials), "Aprocitentan" (1 trials) and "Bemarituzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Biokinetica SA" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Biokinetica SA". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Biokinetica SA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Biokinetica SA, 4 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".